Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lisanne E N Manson"'
Autor:
Lisanne E. N. Manson, Sander J. Delwig, Jos J. M. Drabbels, Daan J. Touw, Aiko P. J. De Vries, Dave L. Roelen, Henk-Jan Guchelaar
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Introduction: Specific alleles in human leukocyte antigens (HLAs) are associated with an increased risk of developing drug hypersensitivity reactions induced by abacavir, allopurinol, carbamazepine, oxcarbazepine, phenytoin, lamotrigine, or flucloxac
Externí odkaz:
https://doaj.org/article/230f6020c8444837b368e8adcb58c81e
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Aim: To provide a comparison of genotyping for HLA risk alleles versus patch testing to determine which of these two tests is a better diagnostic tool for cutaneous hypersensitivity reactions caused by anti-seizure medication.Methods: A literature st
Externí odkaz:
https://doaj.org/article/a3bf0b281cc947b99530858e2c8b2228
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
IntroductionCertain HLA variants are associated with an increased risk of hypersensitivity reactions to specific drugs. Both the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (DPWG) have issue
Externí odkaz:
https://doaj.org/article/d0497354c08249898fddcf8118e7ae7c
Publikováno v:
Pharmaceuticals, Vol 15, Iss 1, p 4 (2021)
Human Leukocyte Antigen (HLA) variants can be a risk factor for developing potentially fatal drug hypersensitivity reactions. Our aim was to estimate the potential impact of genotyping for the HLA risk alleles incorporated in the Dutch Pharmacogeneti
Externí odkaz:
https://doaj.org/article/e3ef54790ddb4f75a6f8b9187587a16f
Autor:
Marty Chaplin, Jamie J. Kirkham, Kerry Dwan, Derek J. Sloan, Geraint Davies, Andrea L. Jorgensen, Irma Aguilar-Delfín, José A G Agúndez, Sophie M Argon, M J Arranz, Derrick A Bennett, Stefan Böhringer, Lawrence Brody, Ingolf Cascorbi, Erika Cecchin, Mandy Crommentuijn-van Rhenen, Ann K Daly, Nur Aizati Athirah Daud, Jorge Duconge, Chiara Fabbri, Alison Fitches, Andrea Gaedigk, Donato Gemmati, Claudia Maria Dan Hawcutt, Rachel Huddart, Evelyne Jacqz-Aigrain, Slobodan M Janković, Theodora Katsila, Gideon Koren, Beata S Lipska-Ziętkiewicz, Thomas Liehr, A H Maitland-van der Zee, Lisanne E N Manson, Martin H Maurer, Juan Eduardo Megías-Vericat, Taichi Ochi, Daniel J O'Connor, Laura B Ramsey, Gad Rennert, Francesco Rucci, Gaetano Santulli, Aris Saoulidis, Rashmi R Shah, Alessandro Serretti, Andrew Somogyi, Gere Sunder-Plassmann, Virginia Boso-Ribelles, Caroline F Thorn, Evangelia Eirini Tsermpini, Satyanarayana Chakradhara Rao Uppugunduri, Michael A van Es, Magdalena Zarowiecki
Publikováno v:
PLoS Medicine
PLOS MEDICINE
Chaplin, M, Kirkham, J, Dwan, K, Sloan, D J, Davies, G & Jorgensen, A L 2020, ' STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline ', PL o S Medicine, vol. 17, no. 9, e1003344 . https://doi.org/10.1371/journal.pmed.1003344
PLoS Medicine, Vol 17, Iss 9, p e1003344 (2020)
PLOS MEDICINE
Chaplin, M, Kirkham, J, Dwan, K, Sloan, D J, Davies, G & Jorgensen, A L 2020, ' STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline ', PL o S Medicine, vol. 17, no. 9, e1003344 . https://doi.org/10.1371/journal.pmed.1003344
PLoS Medicine, Vol 17, Iss 9, p e1003344 (2020)
Background Large sample sizes are often required to detect statistically significant associations between pharmacogenetic markers and treatment response. Meta-analysis may be performed to synthesize data from several studies, increasing sample size a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0723340d500283390e03c6511decabd3
https://doi.org/10.1371/journal.pmed.1003344
https://doi.org/10.1371/journal.pmed.1003344